AMY NIESE: Open Payments
NPI 1396381307 · FINDLAY, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,692 in 102 payments from 19 companies in 2025. Trend: 2023 $177 · 2024 $1,462 · 2025 $1,692
Food & beverage: $1,692
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 35 | $491 |
| AstraZeneca Pharmaceuticals LP | 6 | $190 |
| Novo Nordisk Inc | 14 | $177 |
| Otsuka America Pharmaceutical, Inc. | 6 | $105 |
| Lilly USA, LLC | 7 | $98 |
| PFIZER INC. | 5 | $86 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $78 |
| Phathom Pharmaceuticals, Inc. | 4 | $70 |
| Axsome Therapeutics, Inc. | 3 | $66 |
| Janssen Pharmaceuticals, Inc | 3 | $64 |
Products named: VRAYLAR, AIRSUPRA, REXULTI, QULIPTA, MOUNJARO, Ozempic, NURTEC ODT, CAPLYTA.
Industry payments across OH — which companies pay providers there.
